Inclusion Body Myositis — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Exercise, falls-prevention and swallowing programmes without routine immunosuppression
No immunosuppressive medicine has shown sustained functional benefit in inclusion-body myositis. Management therefore prioritises tailored exercise, mobility and falls interventions, orthotics, swallowing surveillance, nutrition and respiratory assessment.
Reference: NHS England 2025 clinical commissioning policy for therapeutic immunoglobulin (Updated 2025): https://www.england.nhs.uk/wp-content/uploads/2021/12/ccp-for-the-use-of-therapeutic-immunoglobulin-england-2025.pdf; Current review of inclusion-body myositis management (Published 2024): https://pmc.ncbi.nlm.nih.gov/articles/PMC11646336/